Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Prandoni, P.
space
  arrow  Girolami, A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF COMMUNICATION

Use of an Algorithm for Administering Subcutaneous Heparin in the Treatment of Deep Venous Thrombosis

right arrow Paolo Prandoni, MD, PhD; Paola Bagatella, MD; Enrico Bernardi, MD; Bruno Girolami, MD; Laura Rossi, MD; Luigi Scarano, MD; Antonio Marchiori, MD; Andrea Piccioli, MD; and Antonio Girolami, MD

15 August 1998 | Volume 129 Issue 4 | Pages 299-302

Background: Despite the widespread use of subcutaneous heparin in the initial treatment of deep venous thrombosis, there are no guidelines for achieving adequate anticoagulation with this drug.

Objective: To implement a weight-based algorithm for the administration of subcutaneous unfractionated heparin after an intravenous loading dose.

Design: Prospective cohort study.

Setting: University hospital.

Participants: 70 outpatients with proximal venous thrombosis.

Intervention: An intravenous bolus of heparin followed by a subcutaneous injection of heparin in doses adjusted for body weight. Subsequent adjustments of the subcutaneous heparin dose were scheduled twice daily according to the algorithm; the activated partial thromboplastin time (aPT) was measured in the mid-interval (target range, 50 to 90 seconds).

Results: The therapeutic threshold aPT (≥ 50 seconds) was achieved in 61 patients (87%) within 24 hours and in 69 patients (99%) within 48 hours. In 7 patients (10%), a supratherapeutic aPT lasted more than 12 hours. No major bleeding episodes or cases of heparin-induced thrombocytopenia were seen. Three patients (4.3% [95% CI, 0.9% to 12.0%]) had recurrent thromboembolism during 3 months of follow-up.

Conclusion: The administration of subcutaneous heparin according to a weight-based algorithm allows the rapid achievement of effective and safe anticoagulation in patients with deep venous thrombosis.

Author and Article Information
space

From the University of Padua Medical School, Padua, Italy
Requests for Reprints: Paolo Prandoni, MD, PhD, Institute of Medical Semeiotics, University of Padua Medical School, via Ospedale Civile, 105, 35128 Padua, Italy.
Current Author Addresses: Drs. Prandoni, Bagatella, Bernardi, B. Girolami, Rossi, Scarano, Marchiori, Piccioli, and A. Girolami: Institute of Medical Semeiotics, University of Padua Medical School, via Ospedale Civile, 105, 35128 Padua, Italy.


Related articles in Annals:

Letters
Subcutaneous Heparin for Deep Venous Thrombosis
Adriano Alatri, Paolo Bucciarelli, AND Marco Moia
Annals 1999 130: 1027. [Full Text]  

Letters
Subcutaneous Heparin for Deep Venous Thrombosis
Paolo Prandoni
Annals 1999 130: 1027. [Full Text]  



This article has been cited by other articles:


Home page
BloodHome page
P. Prandoni
How I treat venous thromboembolism in patients with cancer
Blood, December 15, 2005; 106(13): 4027 - 4033.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
Writing Committee for the Galilei Investigators
Subcutaneous Adjusted-Dose Unfractionated Heparin vs Fixed-Dose Low-Molecular-Weight Heparin in the Initial Treatment of Venous Thromboembolism
Arch Intern Med, May 24, 2004; 164(10): 1077 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. J. J. van Dongen, R. Vink, B. A. Hutten, H. R. Buller, and M. H. Prins
The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event: A Meta-analysis
Arch Intern Med, June 9, 2003; 163(11): 1285 - 1293.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. Alatri, P. Bucciarelli, and M. Moia
Subcutaneous Heparin for Deep Venous Thrombosis
Ann Intern Med, June 15, 1999; 130(12): 1027 - 1027.
[Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1998 by the American College of Physicians.